NCT07229001
Treating Meibomian Gland Disease in a Pediatric Population
Enrolling by Invitation
NAAges 6–18InterventionalTreatmentIllinois College of OptometryInvestigator-initiated
~15 participants
Updated 2025-11-14 on ClinicalTrials.gov
What's tested:Low level light treatmentwarm compress and artificial tear
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in MG
Measured over 1 months
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesIllinois1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
subjects with severe MGD
Exclusion
i. Thyroid disease ii. Autoimmune disease iii. Diabetes iv. History of ocular surgery other than refractive surgery v. Disfiguring eye trauma vi. Active infections or severe allergic conjunctivitis vii. Currently pregnant or nursing viii. Epilepsy vii.ix. Migraine
What this trial measures
- Change in MG1 months
atrophy score
- MG score1 month
atropine score